Chart – BioSante Pharmaceuticals, Inc – (BPAX)

Dec 04, 2011 No Comments by

By @VexTrades -

Upcoming Events

Phase 3 efficacy data of Libigel for Female sexual dysfunction due 4Q 2011. Safety data due 3Q 2012 and NDA filing due 4Q 2012.

PDUFA 2/14/12 of Bio-T-Gel for male hypogonadism partnered with TEVA.

Click on chart to enlarge, then click on “expand” icon at top right for a clearer image.

 

Charts

About the author

Currently residing in New Zealand and employed in the education industry, Mr. A. Burden holds a M.Com in International Business from the University of Sydney and used these skills together with his passion for investing to establish BioPharmCatalyst in June 2010 as a tool for investing decisions in the US pharmaceutical market. He spends much of his free time mountain biking, playing squash and hiking.
No Responses to “Chart – BioSante Pharmaceuticals, Inc – (BPAX)”

Leave a Reply